Isolation and characterization of squamous cell carcinoma-derived stem-like cells: Role in tumor formation

International Journal of Molecular Sciences

Volumn 14, Issue 10, 2013, Pages 19540-19555

  Dallaglio, Katiuscia ^a   Petrachi, Tiziana ^a   Marconi, Alessandra ^a   Truzzi, Francesca ^a   Lotti, Roberta ^a   Saltari, Annalisa ^a   Morandi, Paolo ^a   Puviani, Mario ^b   Maiorana, Antonino ^a   Roop, Dennis R ^c   Pincelli, Carlo ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b Ospedale Civile di Sassuolo   (Italy)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

1 integrin; Differentiation; Rapidly adhering cells; Skin; Squamous cell carcinoma; Stem cells; Survivin; Tumor formation; Tumorigenesis

Indexed keywords

BETA1 INTEGRIN; CELL MARKER; COLLAGEN TYPE 4; KI 67 ANTIGEN; SILICONE; SURVIVIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CARCINOGENIC ACTIVITY; CELL ADHESION; CELL FUNCTION; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CELL SUBPOPULATION; CELLULAR PARAMETERS; CLINICAL ARTICLE; CLINICAL FEATURE; COLONY FORMING CELL; COLONY FORMING EFFICIENCY; CONTROLLED STUDY; EPITHELIUM TUMOR; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; KERATINOCYTE STEM CELL; METASTASIS; MITOSIS INDEX; MOUSE; NON RAPIDLY ADHERING KERATINOCYTE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAPIDLY ADHERING KERATINOCYTE; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; STEM CELL; TUMOR CELL; TUMOR RECURRENCE;

3T3 CELLS; ANIMALS; ANTIGENS, CD29; CARCINOGENESIS; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; EPIDERMIS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; KERATINOCYTES; MICE; MICE, SCID; REPRESSOR PROTEINS; SKIN NEOPLASMS; STEM CELLS;

EID: 84884831432     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms141019540     Document Type: Article

References (40)

1. Lohmann, C.M.; Solomon, A.R. Clinicopathologic variants of cutaneous squamous cell carcinoma. Adv. Anat. Pathol. 2001, 8, 27-36.
2. Morris, R.J. Keratinocyte stem cells: targets for cutaneous carcinogens. J. Clin. Invest. 2000, 106, 3-8.
3. Lapouge, G.; Youssef, K.K.; Vokaer, B.; Achouri, Y.; Michaux, C.; Sotiropoulou, P.A.; Blanpain, C. Identifying the cellular origin of squamous skin tumors. Proc. Natl. Acad. Sci. USA 2011, 108, 7431-7436.
4. Jones, P.H.; Watt, F.M. Separation of human epidermal stem cells from transit amplyfying cells on the basis of differences in integrin function and expression. Cell 1993, 73, 713-724.
5. Tan, D.W.; Jensen, K.B.; Trotter, M.W.; Connelly, J.T.; Broad, S.; Watt, F.M. Single-cell gene expression profiling reveals functional heterogeneity of undifferentiated human epidermal cells. Development. 2013, 140, 1433-1444.
6. Li, A.; Kaur, P. FACS enrichment of human keratinocyte stem cells. Methods Mol. Biol. 2005, 289, 87-96.
7. Marconi, A.; Dallaglio, K.; Lotti, R.; Vaschieri, C.; Truzzi, F.; Fantini, F.; Pincelli, C. Survivin identifies keratinocyte stem cells and is downregulated by anti-beta1 integrin during anoikis. Stem Cells 2007, 25, 149-155.
8. Wicha, M.A.; Liu, S.; Dontu, G. A Paradigm Shift-Cancer Stem Cells: An Old Idea, a paradigm shift. Cancer Res. 2006, 66, 1883-1890.
9. Welte, Y.; Adjaye, J.; Lehrach, H.R.; Regenbrecht, C.R. Cancer stem cells in solid tumors: Elusive or illusive? Cell Commun. Signal. 2010, 8, 6.
10. Bonnet, D.; Dick, J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 1997, 3, 730-737.
11. Colmont, C.S.; Harding, K.G.; Piguet, V.; Patel, G.K. Human skin cancer stem cells: A tale of mice and men. Exp. Dermatol. 2012, 21, 576-580.
12. Driessens, G.; Beck, B.; Caauwe, A.; Simons, B.D.; Blanpain, C. Defining the mode of tumour growth by clonal analysis. Nature 2012, 488, 527-530.
13. Schober, M.; Fuchs, E. Tumor-initiating stem cells of squamous cell carcinomas and their control by TGF-β and integrin/focal adhesion kinase (FAK) signaling. Proc. Natl. Acad. Sci. USA 2011, 108, 10544-10549.
14. Ridgway, R.A.; Serrels, B.; Mason, S.; Kinnaird, A.; Muir, M.; Patel, H.; Muller, W.J.; Sansom, O.J.; Brunton, V.G. Focal adhesion kinase is required for β-catenin-induced mobilization of epidermal stem cells. Carcinogenesis 2012, 33, 2369-2376.
15. Janes, S.M.; Watt, F.M. Switch from alphavbeta5 to alphavbeta6 integrin expression protects squamous cell carcinomas from anoikis. J. Cell Biol. 2004, 166, 419-431.
16. Jensen, K.B.; Jones, J.; Watt, F.M. A stem cell gene expression profile of human squamous cell carcinomas. Cancer Lett. 2008, 272, 23-31.
17. Clarke, M.F.; Dick, J.E.; Dirks, P.B.; Eaves, C.J.; Jamieson, C.H.; Jones, D.L.; Visvader, J.; Weissman, I.L.; Wahl, G.M. Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 2006, 66, 9339-9344.
18. Rheinwald, J.G.; Beckett, M.A. Defective terminal differentiation in culture as a consistent and selectable character of malignant human keratinocytes. Cell 1980, 22, 629-632.
19. Purdie, K.J.; Pourreyron, C.; South, A.P. Isolation and culture of squamous cell carcinoma lines. Methods Mol. Biol. 2011, 731, 151-159.
20. Janes, S.M.; Watt, F.M. New roles for integrins in squamous-cell carcinoma. Nat. Rev. Cancer 2006, 6, 175-183.
21. Larjava, H.; Peltonen, J.; Akiyama, S.K.; Yamada, S.S.; Gralnick, H.R.; Uitto, J.; Yamada, K.M. Novel function for beta 1 integrins in keratinocyte cell-cell interactions. J. Cell Biol. 1990, 110, 803-815.
22. Taylor, G.; Lehrer, M.S.; Jensen, P.J.; Sun, T.T.; Lavker, R.M. Involvement of follicular stem cells in forming not only the follicle but also the epidermis. Cell 2000, 102, 451-461.
23. Pincelli, C.; Marconi, A. Keratinocyte stem cells: Friends and foes. J. Cell Physiol. 2010, 225, 310-315.
24. Dallaglio, K.; Marconi, A.; Truzzi, F.; Lotti, R.; Palazzo, E.; Petrachi, T.; Saltari, A.; Coppini, M.; Pincelli, C. E-FABP induces differentiation in normal human keratinocytes and modulates the differentiation process in psoriatic keratinocytes in vitro. Exp. Dermatol. 2013, 22, 255-261.
25. Masouyé, I.; Saurat, J.H.; Siegenthaler, G. Epidermal fatty-acid-binding protein in psoriasis, basal and squamous cell carcinomas: An immunohistological study. Dermatology 1996, 192, 208-213.
26. Feng, R.; Zhou, S.; Liu, Y.; Song, D.; Luan, Z.; Dai, X.; Li, Y.; Tang, N.; Wen, J.; Li, L. Sox2 protects neural stem cells from apoptosis via up-regulating survivin expression. Biochem. J. 2013, 450, 459-468.
27. Carter, B.Z.; Qiu, Y.; Huang, X.; Diao, L.; Zhang, N.; Coombes, K.R.; Mak, D.H.; Konopleva, M.; Cortes, J.; Kantarjian, H.M.; et al. Survivin is highly expressed in CD34(+)38(-) leukemic stem/progenitor cells and predicts poor clinical outcomes in AML. Blood 2012, 120, 173-180.
28. Reichert, S.; Rodel, C.; Mirsch, J.; Harter, P.N.; Tomicic, M.T.; Mittelbronn, M.; Kaina, B.; Rödel, F. Survivin inhibition and DNA double-strand break repair: A molecular mechanism to overcome radioresistance in glioblastoma. Radiother. Oncol. 2011, 101, 51-58.
29. Acquati, S.; Greco, A.; Licastro, D.; Bhagat, H.; Ceric, D.; Rossini, Z.; Grieve, J.; Shaked-Rabi, M.; Henriquez, N.V.; Brandner, S.; et al. Epigenetic regulation of survivin by Bmi1 is cell type specific during corticogenesis and in gliomas. Stem Cells 2013, 31, 190-202.
30. Beck, B.; Driessens, G.; Goossens, S.; Youssef, K.K.; Kuchnio, A.; Caauwe, A.; Sotiropoulou, P.A.; Loges, S.; Lapouge, G.; Candi, A.; et al. A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours. Nature 2011, 478, 399-403.
31. Ghadially, R. 25 years of epidermal stem cell research. J. Invest. Dermatol. 2012, 132, 797-810.
32. Patel, G.K.; Yee, C.L.; Terunuma, A.; Telford, W.G.; Voong, N.; Yuspa, S.H.; Vogel, J.C. Identification and characterization of tumor-initiating cells in human primary cutaneous squamous cell carcinoma. J. Invest. Dermatol. 2012, 132, 401-409.
33. Sun, Y.; Kong, W.; Falk, A.; Hu, J.; Zhou, L.; Pollard, S.; Smith, A. CD133 (Prominin) negative human neural stem cells are clonogenic and tripotent. PLoS One 2009, 4, e5498.
34. Jeong, H.W.; Kim, I.S. TGF-beta1 enhances betaig-h3-mediated keratinocyte cell migration through the alpha3beta1 integrin and PI3K. J. Cell. Biochem. 2004, 92, 770-780.
35. Reuter, J.A.; Ortiz-Urda, S.; Kretz, M.; Garcia, J.; Scholl, F.A.; Pasmooij, A.M.; Cassarino, D.; Chang, H.Y.; Khavari, P.A. Modeling inducible human tissue neoplasia identifies an extracellular matrix interaction network involved in cancer progression. Cancer Cell 2009, 15, 477-488.
36. Ferreira, M.; Fujiwara, H.; Morita, K.; Watt, F.M. An activating beta1 integrin mutation increases the conversion of benign to malignant skin tumors. Cancer Res. 2009, 15, 1334-1342.
37. Dallaglio, K.; Marconi, A.; Pincelli, C. Survivin: A dual player in healthy and diseased skin. J. Invest. Dermatol. 2012, 132, 18-27.
38. Altieri, D.C. Targeting survivin in cancer. Cancer Lett. 2013, 332, 225-228.
39. Gandarillas, A.; Watt, F.M. c-Myc promotes differentiation of human epidermal stem cells. Genes Dev. 1997, 11, 2869-2882.
40. Worst, P.K.; Mackenzie, I.C.; Fusenig, N.E. Reformation of organized epidermal structure by transplantation of suspensions and cultures of epidermal and dermal cells. Cell Tissue Res. 1982, 225, 65-77.